Clinical Trial Detail

NCT ID NCT03338959
Title Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

sarcoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.